Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Adv Neonatal Care. 2012 Apr;12(2):107–111. doi: 10.1097/ANC.0b013e31824c1583

Table 1.

Medications for Premedication for Nonemergent Intubation

Medicationa Dosage Rangeb,c Onset of Actiona,c Duration of Actiona,c Common Adverse Effectsa
Atropine* 10–20 mcg/kg 1–2 minutes 30–120 minutes Tachycardia, dry hot skin

Glycopyrrolate 5 mcg/kg 1–10 minutes 360 minutes Tachycardia, arrhythmias, bronchospasm

Fentanyl* 1.5–4 mcg/kg Almost immediate 30–60 minutes Apnea, hypotension, CNS depression, chest wall rigidity

Remifentanil 1–3 mcg/kg Almost immediate 3–10 minutes Apnea, hypotension, CNS depression, chest wall rigidity
Morphine 100–300 mcg/kg 5–15 minutes 180–300 minutes Apnea, hypotension, CNS depression
Midazolam 200 mcg/kg 1–5 minutes 20–30 minutes Apnea, hypotension, CNS depression
Thiopental 2–6 mg/kg 30–60 seconds 5–30 minutes Histamine release, apnea, hypotension, bronchospasm
Propofol 1–2.5 mg/kg < 30 seconds 3–10 minutes Histamine release, apnea, hypotension, bronchospasm, bradycardia; pain at injection site

Vecuronium* 100 mg/kga 2–3 minutes 30–40 minutes Mild histamine release, hypertension/hypotension, tachycardia, arrhythmias, bronchospasm
Rocuronium* 500 mcg/kg 1–2 minutes 20–30 minutes Mild histamine release, hypertension/hypotension, tachycardia, arrhythmias, bronchospasm

Pancuronium 50–100 mcg/kga 1–3 minutes 40–60 minutes Mild histamine release, hypertension, tachycardia, bronchospasm, excessive salivation
Succinylcholine 1–2 mg/kg 30–60 seconds 4–6 minutes Hypertension/hypotension, tachycardia, arrhythmias, bronchospasm, hyperkalemia, myoglobinemia, malignant hypertension
a

Based on information provided by AAP recommendations for premedication for nonemergent intubation10

b

Range of doses utilized in the clinical trials reviewed

c

All dosages and pharmacokinetics based on intravenous (IV) administration

*

Preferred medication by the AAP10